194 related articles for article (PubMed ID: 27607335)
1. Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis.
Zittan E; Milgrom R; Ma GW; Wong-Chong N; OʼConnor B; McLeod RS; MacRae HM; Greenberg GR; Nguyen GC; Croitoru K; Steinhart AH; Cohen Z; Silverberg MS
Inflamm Bowel Dis; 2016 Oct; 22(10):2442-7. PubMed ID: 27607335
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
Runde J; Erondu A; Akiyama S; Traboulsi C; Rai V; Glick LR; Yi Y; Ollech JE; Cohen RD; Skowron KB; Hurst RD; Umanskiy K; Shogan BD; Hyman NH; Rubin MA; Dalal SR; Sakuraba A; Pekow J; Chang EB; Rubin DT
Inflamm Bowel Dis; 2022 Sep; 28(9):1386-1394. PubMed ID: 35040964
[TBL] [Abstract][Full Text] [Related]
3. Operative strategy modifies risk of pouch-related outcomes in patients with ulcerative colitis on preoperative anti-tumor necrosis factor-α therapy.
Gu J; Remzi FH; Shen B; Vogel JD; Kiran RP
Dis Colon Rectum; 2013 Nov; 56(11):1243-52. PubMed ID: 24104999
[TBL] [Abstract][Full Text] [Related]
4. Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis.
Gainsbury ML; Chu DI; Howard LA; Coukos JA; Farraye FA; Stucchi AF; Becker JM
J Gastrointest Surg; 2011 Mar; 15(3):397-403. PubMed ID: 21246415
[TBL] [Abstract][Full Text] [Related]
5. Association of Preoperative Anti-Tumor Necrosis Factor Therapy With Adverse Postoperative Outcomes in Patients Undergoing Abdominal Surgery for Ulcerative Colitis.
Kulaylat AS; Kulaylat AN; Schaefer EW; Tinsley A; Williams E; Koltun W; Hollenbeak CS; Messaris E
JAMA Surg; 2017 Aug; 152(8):e171538. PubMed ID: 28614561
[TBL] [Abstract][Full Text] [Related]
6. Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis.
Huguet M; Pereira B; Goutte M; Goutorbe F; Dubois A; Bommelaer G; Buisson A
Inflamm Bowel Dis; 2018 Jan; 24(2):261-268. PubMed ID: 29361101
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis.
Lightner AL; Tse CS; Quinn K; Bergquist JR; Enders F; Pendegraft R; Khanna S; Raffals L
Inflamm Bowel Dis; 2017 Jul; 23(7):1195-1201. PubMed ID: 28410344
[TBL] [Abstract][Full Text] [Related]
8. Comparison of health-related quality of life and disability in ulcerative colitis patients following restorative proctocolectomy with ileal pouch-anal anastomosis versus anti-tumor necrosis factor therapy.
van Gennep S; Sahami S; Buskens CJ; van den Brink GR; Ponsioen CY; D'Hoore A; de Buck van Overstraeten A; van Assche G; Ferrante M; Vermeire S; Bemelman WA; D'Haens GR; Löwenberg M
Eur J Gastroenterol Hepatol; 2017 Mar; 29(3):338-344. PubMed ID: 27902515
[TBL] [Abstract][Full Text] [Related]
9. Equivalent function, quality of life and pouch survival rates after ileal pouch-anal anastomosis for indeterminate and ulcerative colitis.
Delaney CP; Remzi FH; Gramlich T; Dadvand B; Fazio VW
Ann Surg; 2002 Jul; 236(1):43-8. PubMed ID: 12131084
[TBL] [Abstract][Full Text] [Related]
10. Health-related quality of life and disability in patients with ulcerative colitis and proctocolectomy with ileoanal pouch versus treatment with anti-TNF agents.
Meijs S; Gardenbroek TJ; Sprangers MA; Bemelman WA; Buskens CJ; D'Haens GR; Löwenberg M
J Crohns Colitis; 2014 Jul; 8(7):686-92. PubMed ID: 24418659
[TBL] [Abstract][Full Text] [Related]
11. Long-term quality of life associated with early surgical complications in patients with ulcerative colitis after ileal pouch-anal anastomosis: A single-center retrospective study.
Xu W; Ye H; Zhu Y; Ding W; Fu J; Cui L; Du P
Int J Surg; 2017 Dec; 48():174-179. PubMed ID: 29104126
[TBL] [Abstract][Full Text] [Related]
12. Similar functional results and complications after ileal pouch-anal anastomosis in patients with indeterminate vs ulcerative colitis.
Dayton MT; Larsen KR; Christiansen DD
Arch Surg; 2002 Jun; 137(6):690-4; discussion 694-5. PubMed ID: 12049540
[TBL] [Abstract][Full Text] [Related]
13. Preoperative exposure to anti-tumor necrosis factor therapy in ulcerative colitis patients undergoing ileal pouch-anal anastomosis (IPAA) is not associated with histological fibrosis: A case control study.
Zittan E; Muir J; Milgrom R; Berns M; Gralnek IM; Cohen Z; Riddell R; Silverberg MS
Int J Surg; 2019 May; 65():80-85. PubMed ID: 30926567
[TBL] [Abstract][Full Text] [Related]
14. Risk factors associated with portomesenteric venous thrombosis in patients undergoing restorative proctocolectomy for medically refractory ulcerative colitis.
Gu J; Stocchi L; Gorgun E; Remzi FH
Colorectal Dis; 2016 Apr; 18(4):393-9. PubMed ID: 26773547
[TBL] [Abstract][Full Text] [Related]
15. Previous infliximab therapy and postoperative complications after proctocolectomy with ileum pouch anal anastomosis.
Eshuis EJ; Al Saady RL; Stokkers PC; Ponsioen CY; Tanis PJ; Bemelman WA
J Crohns Colitis; 2013 Mar; 7(2):142-9. PubMed ID: 22542056
[TBL] [Abstract][Full Text] [Related]
16. Ileorectal anastomosis in comparison with ileal pouch anal anastomosis in reconstructive surgery for ulcerative colitis--a single institution experience.
Andersson P; Norblad R; Söderholm JD; Myrelid P
J Crohns Colitis; 2014 Jul; 8(7):582-9. PubMed ID: 24315777
[TBL] [Abstract][Full Text] [Related]
17. Survival of ileal pouch anal anastomosis constructed after colectomy or secondary to a previous ileorectal anastomosis in ulcerative colitis patients: a population-based cohort study.
Landerholm K; Abdalla M; Myrelid P; Andersson RE
Scand J Gastroenterol; 2017 May; 52(5):531-535. PubMed ID: 28102092
[TBL] [Abstract][Full Text] [Related]
18. Anti-TNF and Pouch Surgery for Ulcerative Colitis: The Ones who Blame for More Complications?
Bislenghi G; Ferrante M; D'Hoore A
Curr Drug Targets; 2019; 20(13):1349-1355. PubMed ID: 30919776
[TBL] [Abstract][Full Text] [Related]
19. Surgical Outcomes in Vedolizumab-Treated Patients with Ulcerative Colitis.
Lightner AL; McKenna NP; Moncrief S; Pemberton JH; Raffals LE; Mathis KL
Inflamm Bowel Dis; 2017 Dec; 23(12):2197-2201. PubMed ID: 28858072
[TBL] [Abstract][Full Text] [Related]
20. Incidence of neoplasias and effectiveness of postoperative surveillance endoscopy for patients with ulcerative colitis: comparison of ileorectal anastomosis and ileal pouch-anal anastomosis.
Ishii H; Hata K; Kishikawa J; Anzai H; Otani K; Yasuda K; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Nozawa H; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T
World J Surg Oncol; 2016 Mar; 14():75. PubMed ID: 26960982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
